Phase II/III (Integrated)

401 trials 182 recruiting

Filter these 401 trials by condition, country, sponsor and more.

Open in Search →

A clinical study of enlicitide in children with high cholesterol (MK-0616-029) Recruiting

2024-519068-42-00 Heterozygous Familial Hypercholesterolemia in pediatr 2026-02-12
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Framework for Optimizing, Refining, and Unifying Manage 2025-12-24
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 2025-11-28
A Study of Navlimetostat (BMS-986504) in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy… Recruiting

2025-521511-40-00 metastatic non-small cell lung cancer 2025-11-18
A study to assess the effect and safety of efgartigimod IV in participants from 12 years to less than 18 years of age with chronic Immune Th… Recruiting

2025-521055-23-00 Chronic Idiopathic thrombocytopenic purpura 2025-10-07
Open-label Study of ELA026 in Participants with sHLH (short title) Recruiting

2025-520624-25-00 Secondary Hemophagocytic Lymphohistiocytosis (sHLH) 2025-09-19
Impact of dapagliflozin for the regulation of immunological activity in Membranous Nephropathy Recruiting

2023-507658-34-00 Membranous Nephropathy 2025-09-19
A phase 2/3, multi-center, study of L-Annamycin in combination with cytarabine vs. placebo in combination with cytarabine as second line the… Recruiting

2024-518359-47-00 Acute Myeloid Leukemia 2025-06-17
A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK10… Recruiting

2024-512659-19-00 Advanced Melanoma 2025-03-31
Effect of immunotherapy in patients with oligo-metastatic (limited number of metastases) non-small cell lung cancer after being treated with… Recruiting

2023-508741-40-00 Non-small cell lung cancer 2025-01-14
Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis … Recruiting

2024-519778-38-00 squizophrenia 2024-12-02
A phase 3 multi-center trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroids in children (ag… Recruiting

2023-503630-44-00 Treatment of moderate-to-severe Atopic dermatitis 2024-11-20
Randomized phase II study comparing 5FU/LV+Nal-IRI, gemcitabine+Nab-paclitaxel or a sequential regimen of 2 months 5FU/LV+Nal-IRI followed b… Recruiting

2024-518143-38-00 Metastatic pancreatic cancer 2024-10-25
An Open-label, Rollover Study of Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib Study Recruiting

2024-512217-40-00 Malignant Solid Tumors 2024-10-11
A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE® and Narrow-Band Ultraviolet B (NB-UVB) Light versu… Recruiting

2023-507470-40-00 Vitiligo 2024-08-27
A Study of Zanubrutinib Versus Tacrolimus in Participants With Primary Membranous Nephropathy (ALMOND) Recruiting

2022-501147-32-00 Primary Membranous Nephropathy 2024-07-11
Safety and efficacy of anakinra treatment for patients with persistent respiratory symptoms post acute covid and immune system activation: t… Recruiting

2023-508123-12-00 Post-Acute COVID Syndrome (PACS) 2023-11-03
Open-label, long-term safety, efficacy, and pharmacokinetics study of vibegron in pediatric subjects 2 years to < 18 years of age with NDO a… Recruiting

2024-513995-16-00 Neurogenic Detrusor Overactivity (NDO) 2023-07-28
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 2023-07-17
A Phase 2/3 Safety, Pharmacokinetics, and Efficacy Study ofNirmatrelvir/Ritonavir in Pediatric, Nonhospitalized Symptomatic Participants Wit… Recruiting

2023-509773-23-00 SARS-CoV-2 Infection 2023-07-13
OLE study in participants with pulmonary arterial hypertension Recruiting

2023-505539-11-00 Pulmonary Arterial Hypertension 2023-04-06
A Study to Compare the Efficacy and Safety of Oral Azacitidine (Oral-Aza, ONUREG®) plus BSC versus Placebo plus BSC in Participants with IPS… Recruiting

2022-500479-29-00 International Prognostic Scoring System-Revised (IPSS-R 2023-03-28
Satisfaction study of split doses botulinum toxin with double frequency Recruiting

2025-520915-14-00 Wrinkles, fine lines 2023-01-12
Long-Term Safety and Efficacy evaluation of amlitelimab in participants of previous amlitelimab moderate to severe atopic dermatitis clinica… Recruiting

2023-506548-18-00 Dermatitis atopic 2022-11-10